Egeria’s Acquisition of Isoplus

Poellath, Lakatos, Koves and Partners and Clifford Chance advised Egeria on the deal. The independent pan-European investment firm Egeria announced the acquisition of the isoplus Group, a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

CordenPharma’s Acquisition of Finished Drug Product Manufacturing Business From Vifor Pharma

Kellerhals Carrard advised Vifor Pharma on this transaction. Vifor Pharma Participations AG (Vifor Pharma) closed its divestment transaction regarding its finished drug product manufacturing business with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here